Virtual Research Poster Session
The Virtual Research Poster Session highlights the research of MS trainees and staff from across the country. Click on each research listing to learn more about how each researcher is helping to advance treatment and care, enhance well-being, understand and halt disease progression, and prevent MS.
A Ketogenic Diet Improves Clinical Scores in a Mouse Model of MS
Nima Alaeiilkhchi, University of British Columbia
Goal: Advance Treatment and Care
Humanizing mouse models of MS to evaluate Epstein Barr virus infection as a risk factor for disease
Jessica Allanach, University of British Columbia
Goal: Prevent MS
Il-1 Receptor Antagonist: A New Biomarker Found in Blood that Correlates with Disability and Neurofilament Light in Multiple Sclerosis
Stephanie Blandford, Memorial University of Newfoundland
Goal: Understand and Halt Disease Progression
Why does our society think it’s acceptable for younger adults with MS to live in long term care facilities? Using a Foucauldian genealogical approach to challenge the values in our care system.
Michelle Hewitt, University of British Columbia - Okanagan
Goal: Enhance Well-being
Neuregulin-1 is implicated in pathogenesis of multiple sclerosis and its availability ameliorates experimental autoimmune encephalomyelitis
Hardeep Kataria, University of Manitoba
Goal: Understand and Halt Disease Progression
New theory shines light on how antibodies made by persons living with MS injure nerve cells
Cole Libner, University of Saskatchewan
Goal: Understand and Halt Disease Progression
Childhood Maltreatment May be Relevant to Pain Management in Multiple Sclerosis and Other Immune Disease
Tyler MacDonald, Dalhousie University
Goal: Advance Treatment and Care
Impact of Dietary Methionine Restriction on Lymphocytes Ability to Invade the Brain and Spinal Cord in Neuroinflammation
Victoria Mamane, University of Montreal
Goal: Prevent MS
Metagenomic analysis of the pediatric multiple sclerosis microbiome
Ali Mirza, University of British Columbia
Goal: Prevent MS
Disease-modifying Drug Safety and Effectiveness in Multiple Sclerosis (DRUMS)
Huah Shin Ng, University of British Columbia
Goal: Advance Treatment and Care
A novel protein complex in Multiple Sclerosis
Tautvydas Paskevicius, University of Alberta
Goal: Understand and Halt Disease Progression
Prioritizing the Healthcare Access Concerns of Canadians with MS
Julie Petrin, Queen's University
Goal: Enhance Well-being
Astrocytes: the cells with a "particular set of skills..."
Jacqueline Reid, University of Calgary
Goal: Understand and Halt Disease Progression
Childhood maltreatment and psychiatric comorbidity in multiple sclerosis and other immune mediated inflammatory disorders
Anthony Wan, University of Manitoba
Goal: Advance Treatment and Care
Making a favourable survival environment for protective immune cells inside the inflamed brain
Angela Wang, University of Toronto
Goal: Understand and Halt Disease Progression